Corticotropin-releasing hormone differentially modulates the interleukin-1 system according to the level of monocyte activation by endotoxin
The interleukin-1 (IL-1) system is constituted by IL-1 alpha and IL-1 β and IL-1 receptor antagonist (IL-1ra) that bind the same IL-1 receptors. Hypothalamic-pituitary-adrenal axis hormones are major mediators of the neuroendocrine control over immune function. Corticotropin-releasing hormone (CRH)...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , , , , , |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
1995
|
| Acceso en línea: | Registro en Scopus DOI Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 14817caa a22012737a 4500 | ||
|---|---|---|---|
| 001 | PAPER-12517 | ||
| 003 | AR-BaUEN | ||
| 005 | 20230518204242.0 | ||
| 008 | 190411s1995 xx ||||fo|||| 00| 0 eng|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-0028847347 | |
| 024 | 7 | |2 cas |a corticotropin releasing factor, 9015-71-8; Corticotropin-Releasing Hormone, 9015-71-8; Cyclic AMP, 60-92-4; interleukin 1 receptor antagonist protein; Interleukin-1; Lipopolysaccharides; RNA, Messenger; Sialoglycoproteins | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 100 | 1 | |a Pereda, M.P. | |
| 245 | 1 | 0 | |a Corticotropin-releasing hormone differentially modulates the interleukin-1 system according to the level of monocyte activation by endotoxin |
| 260 | |c 1995 | ||
| 270 | 1 | 0 | |m Pereda, M.P.; Instituto de Investigaciones Médicas, Universidad de Buenos Aires, Donato Alvarez 3150, 1427, Buenos Aires, Argentina |
| 506 | |2 openaire |e Política editorial | ||
| 504 | |a Besedovsky, H., Del Rey, A., Immune-endocrine circuits: Integrative role of cytokines (1992) Front Neuroendocrinol, 13, pp. 61-94 | ||
| 504 | |a Bateman, A., Singh, A., Krai, T., Solomon, S., The immune-hypothalamic-pituitary-adrenal axis (1989) Endocr Rev, 10, pp. 92-111 | ||
| 504 | |a Dinarello, C.A., Role of interleukin-1 in infectious diseases (1992) Immunol Rev, 127, pp. 119-146 | ||
| 504 | |a Arend, W.P., Interleukin 1 receptor antagonist. A new member of the interleukin 1 family (1991) J Clin Invest, 88, pp. 1445-1451 | ||
| 504 | |a Eisenberg, S.P., Evans, R.J., Arend, W.P., Verderber, E., Brewer, M.T., Hannum, C.H., Thompson RC1990 Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist Nature, 343, pp. 341-346 | ||
| 504 | |a Andersson, L.B., Bjôrk, L., Dinarello, C.A., Towbin, H., Ersson, U., Lipopolysaccharide induces human interleukin-1 receptor antagonist and interleukin-1 production in the same cell (1992) Eur J Immunol, 22, pp. 2617-2623 | ||
| 504 | |a Fischer, E., Van Zee, K.J., Marano, M.A., Rock, C.S., Kenney, J.S., Poutsiaka, D.D., Dinarello, C.A., Moldawer, L.L., Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease (1992) Blood, 79, pp. 2196-2200 | ||
| 504 | |a Chomarat, P., Vannier, E., Dechanet, J., Rissoan, M.C., Banchereau, J., Dinarello, C.A., Miossec, P., Balance of IL-1 receptor antagonist/ IL-1β in rheumatoid synovium and its regulation by IL-4 and IL-10 (1995) J Immunol, 154, pp. 1432-1437 | ||
| 504 | |a Poutsiaka, D.D., Clark, B.D., Vannier, E., Dinarello, C.A., Production of interleukin-1 receptor antagonist and interleukin-1β by peripheral blood mononuclear cells is differentially regulated (1991) Blood, 78, pp. 1275-1281 | ||
| 504 | |a Arend, W.P., Smith, M.F., Janson, R.W., Joslin, F.G., IL-1 receptor antagonist and IL-1β production in human monocytes are regulated differently (1991) J Immunol, 147, pp. 1530-1536 | ||
| 504 | |a Turner, M., Chantry, M.D., Katsikis, P., Berger, A., Brennan, F.M., Feldmann, M., Induction of the interleukin 1 receptor antagonist protein by transforming growth factor (1991) Eur J Immunol, 21, pp. 1635-1639 | ||
| 504 | |a Fenton, M.J., Buras, J.A., Donnelly, R.P., (1992) J Immunol, 149, pp. 1283-1288 | ||
| 504 | |a Arzt, E., Sauer, J., Pollmacher, T., Labeur, M., Holsboer, F., Reul, J., Stalla, G.K., Glucocorticoids suppress interleukin 1 receptor antagonist synthesis following induction by endotoxin (1994) Endocrinology, 134 | ||
| 504 | |a Irwin, M., Stress induced immune suppression: Role of brain corticotropin-releasing hormone and autonomic nervous system mechanisms (1994) Adv Neuroimmunol, 4, pp. 29-47 | ||
| 504 | |a Vamkopoulos, N.C., Chrousos, G.P., Hormonal regulation of human corticotropin-releasing hormone gene expression: Implications for the stress response and immune/inflammatory reaction (1994) Endocr Rev, 15, pp. 409-420 | ||
| 504 | |a Holsboer, F., Spengler, D., Heuser, I., The role of corticotropinreleasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia (1992) Progress in Brain Research., 93, pp. 385-415. , Swaab DF, Hofman M, Mirmiran R, Ravid R, van Leeuwen FW (eds), Elsevier, Amsterdam | ||
| 504 | |a Muglia, L., Jacobson, L., Dikkes, P., Majzoub, J.A., Corticotropinreleasing hormone deficiency reveals major fetal but not adult glucocorticoid need (1995) Nature, 373, pp. 427-432 | ||
| 504 | |a Irwin, M.R., Vale, W., Rivier, C., Central corticotropin releasing factor mediates the suppressive effects of stress on natural killer cytotoxicity (1990) Endocrinology, 126, pp. 2837-2844 | ||
| 504 | |a Irwin, M., Brain corticotropin-releasing hormone and interleukin-1 | ||
| 504 | |a Labeur, M.S., Arzt, E., Wiegers, G.J., Holsboer, F., Reul, J., Long-term intracerebroventricular corticotropin-releasing hormone administration induces distinct changes in rat splenocyte activation and cytokine expression (1995) Endocrinology, 136, pp. 2678-2688 | ||
| 504 | |a Sternberg, E.M., Young, W.S., Bernardini, R., Calogero, A.E., Chrousos, G.P., Gold, P.W., Wilder, R.L., A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats (1989) Proc Natl Acad Sci USA, 86, pp. 4771-4775 | ||
| 504 | |a Karalis, K., Sano, H., Redwine, J., Listwak, S., Wilder, R.L., Chrousos, G.P., Autocrine or paracrine inflammatory actions of corticotropinreleasing hormone in vivo (1991) Science, 254, pp. 421-423 | ||
| 504 | |a Crofford, L.J., Sano, H., Karalis, K., Webster, E.L., Goldmuntz, E.A., Chrousos, G.P., Wilder, R.L., Local secretion of corticotropinreleasing hormone in the joints of Lewis rats with inflammatory arthritis (1992) J Clin Invest, 90, pp. 2555-2564 | ||
| 504 | |a Mc Gillis, J.P., Park, P., Rubin-Fletter, P., Turck, C., Dallman, L.F., Payan, D.G., Stimulation of rat B-lymphocyte proliferation by corticotropin releasing factor (1989) J Neurosci Res, 23, pp. 346-352 | ||
| 504 | |a Singh, V.K., Stimulatory effect of corticotropin releasing hormone on human lymphocyte proliferation and interleukin-2 receptor expression (1989) J Neuroimmunol, 23, pp. 257-262 | ||
| 504 | |a Pawlikowski, M., Zelazowski, P., Dohler, K., Stepien, H., Effects of two neuropeptides, somatoliberin (GRF) and corticoliberin (CRF), on human lymphocyte natural killer activity (1988) Brain Behav Immunol, 2, pp. 50-56 | ||
| 504 | |a Singh, V.K., Warren, R.P., White, E.D., Leu, S.J., Corticotropin releasing factor induced stimulation of immune functions (1990) Ann NY Acad Sci, 594, pp. 416-419 | ||
| 504 | |a Singh, V.K., Leu, S.-J., (1990) Neurosci Lett, 120, pp. 151-154 | ||
| 504 | |a Leu, S.J., Singh, V.K., Stimulation of interleukin 6 production by corticotropin releasing factor (1992) Cell Immunol, 143, pp. 220-227 | ||
| 504 | |a Hagan, P., Poole, S., Bristow, A., Immunosuppressive activity of CRF. Inhibition of IL-1 and IL-6 production by human mononuclear cells (1992) Biochem J, 281, pp. 251-254 | ||
| 504 | |a Webster, E.L., Tracey, D.E., Jutila, M.A., Wolfe, S.A., De Souza, E.B., Corticotropin releasing factor receptors in mouse spleen: Identification of receptor bearing cells as resident macrophages (1990) Endocrinology, 127, pp. 440-452 | ||
| 504 | |a Singh, V.K., Fudenberg, H.H., Binding of 125I corticotropin releasing factor to blood immunocytes and its reduction in Alzheimer's disease (1988) Immunol Lett, 18, pp. 5-8 | ||
| 504 | |a Webster, E.L., Battaglia, G., De Souza, E.B., Functional corticotropin-releasing factor (CRF) receptors in mouse spleen: Evidence from adenylate cyclase studies (1989) Peptides, 10, pp. 395-401 | ||
| 504 | |a Tsagarakis, S., Grossman, A., Corticotropin-releasing hormone: Interactions with the immune system (1994) Neuroimmunomodulation, 1, pp. 329-334 | ||
| 504 | |a Wei, E.T., Kiang, J.G., Inhibition of protein exudation from the trachea by corticotropin-releasing factor (1987) Eur J Pharmacol, 140, pp. 63-67 | ||
| 504 | |a Wei, E.T., Kiang, J.G., Peptides of the corticoliberin superfamily attenuate thermal and neurogenic inflammation in rat pawskin (1989) Eur J Pharmacol, 168, pp. 81-86 | ||
| 504 | |a Arzt, E., Stelzer, G., Renner, U., Lange, M., Miiller, O.A., Stalla, G.K., Interleukin-2 and interleukin-2 receptor expression in human cor-ticotrophic adenoma and murine pituitary cell cultures (1992) J Clin Invest, 90, pp. 1944-1951 | ||
| 504 | |a Nishida, T., Nishino, N., Takano, M., Kawai, K., Bando, K., Masui, Y., Nakai, S., Hirai, Y., (1987) Biochem Biophys Res Commun, 143, pp. 345-35223 | ||
| 504 | |a Stalla, G.K., Stalla, J., Von Werder, K., Muller, O.A., Gerzer, R., Hollt, V., Jakobs, K., Nitroimidazole derivatives inhibit anterior pituitary cell function apparently by a direct effect on the catalytic subunit of the adenylate cyclase holoenzyme (1989) Endocrinology, 125, pp. 699-706 | ||
| 504 | |a Plotsky, P.M., Bruhn, T.O., Vale, W., Hypophysiotropic regulation of adrenocorticotropin secretion in response to insulin-induced hypoglycemia (1985) Endocrinology, 117, pp. 323-329 | ||
| 504 | |a Crofford, L.J., Sano, H., Karalis, K., Friedman, T.C., Epps, F., Remmers, E.F., Mathem, P., Wilder, R.L., Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis (1993) J Immunol, 141, pp. 1-10 | ||
| 504 | |a Stephanou, A., Jessop, D.S., Knight, R.A., Lightman, S.L., Corticotropin-releasing factor-like immunoreactivity and mRNA in human leukocytes (1990) Brain Behav Immunol, 4, pp. 67-73 | ||
| 504 | |a Ekman, R., Servenius, B., Castro, M.G., Lowry, P.J., Cederlund, A.S., Bergman, O., Sjogren, H.O., Biosynthesis of corticotropin-releasing hormone in human T-lymphocytes (1993) J. Neuroimmunol, 44, pp. 7-14 | ||
| 504 | |a Kravchenko, I.V., Furalev, V.A., Secretion of immunoreactive corticotropin-releasing factor and adrenocorticotropic hormone by Tand B lymphocytes in response to cellular stress factors (1994) Biochem Biophys Res Commun, 204, pp. 828-834 | ||
| 504 | |a Sasaki, A., Liotta, A.S., Luckey, M.M., Margioris, A.N., Suda, T., Krieger, D.T., Immunoreactive corticotropin-releasing factor is present in human maternal plasma during the third trimester of pregnancy (1984) J Clin Endocrinol Metab, 59, pp. 812-814 | ||
| 504 | |a Gibbs, D.M., Vale, W., Presence of corticotropin-releasing factorlike immunoreactivity in hypophysial portal blood (1982) Endocrinology, 111, pp. 1418-1420 | ||
| 504 | |a Payne, L.C., Weigent, D.A., Blalock, E., Induction of pituitary sensitivity to interleukin-1: A new function for corticotropin-releasing hormone (1994) Biochem Biophys Res Commun, 198, pp. 480-484 | ||
| 504 | |a Ohmori, Y., Strassman, G., Hamilton, T.A., (1990) J Immunol, 145, pp. 3333-3339 | ||
| 504 | |a Hurme, M., Serkkola, E., Ronni, T., Silvennoinen, O., Control of IL-1β expression by protein kinase C and cyclic adenosine monophosphate in myeloid leukemia cells (1990) Blood, 76, pp. 2198-2203 | ||
| 504 | |a Tennenbaum, C.S., Hamilton, T.A., Lipopolysaccharide-induced gene expression in murine peritoneal macrophages is selectively suppressed by agents that elevate intracellular cAMP (1989) J Immunol, 142, pp. 1274-1280 | ||
| 504 | |a Willis, S., Nisen, P., Inhibition of lipopolysaccharide-induced IL-1β transcription by cyclic adenosine monophosphate in human astrocytic cells (1995) J Immunol, 154, pp. 1399-1406 | ||
| 520 | 3 | |a The interleukin-1 (IL-1) system is constituted by IL-1 alpha and IL-1 β and IL-1 receptor antagonist (IL-1ra) that bind the same IL-1 receptors. Hypothalamic-pituitary-adrenal axis hormones are major mediators of the neuroendocrine control over immune function. Corticotropin-releasing hormone (CRH) is produced in peripheral inflammatory sites; its direct effects on inflammatory cytokine synthesis, however, remain unclear. We have studied the effects of CRH (0.1-100 nM) on IL-1 β and IL-1ra expression by human peripheral monocytes in culture activated with different doses of lipopolysaccharide (LPS). In the absence of LPS, CRH up-regulated IL-1ra and IL-1 β messenger RNA expression as well as protein synthesis. No significant changes were observed with low doses of LPS (1 ng/ml). In contrast, in combination with high doses of LPS (1 μ/ml), CRH caused inhibition of IL-1ra and IL-1 β transcription and secretion. The CRH effects were blocked by its antagonist alpha-helical CRH and mediated by intracellular cAMP. These data indicate that CRH modulates the IL-1 system; depending on the state of activation of the monocyte, CRH exerts an inhibitory control on the activated cell and a stimulatory action on the resting monocyte. © 1995 by The Endocrine Society. |l eng | |
| 593 | |a Instituto de Investigaciones Médicas, Universidad de Buenos Aires, Buenos Aires, Argentina | ||
| 593 | |a Departamento de Biología-FCEN, Universidad de Buenos Aires, Buenos Aires, Argentina | ||
| 593 | |a Max-Planck Institute of Psychiatry, Clinical Institute, Munich, 80804, Germany | ||
| 690 | 1 | 0 | |a CORTICOTROPIN RELEASING FACTOR |
| 690 | 1 | 0 | |a INTERLEUKIN 1 |
| 690 | 1 | 0 | |a INTERLEUKIN RECEPTOR |
| 690 | 1 | 0 | |a ARTICLE |
| 690 | 1 | 0 | |a CORTICOTROPIN RELEASE |
| 690 | 1 | 0 | |a HUMAN |
| 690 | 1 | 0 | |a HUMAN CELL |
| 690 | 1 | 0 | |a HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM |
| 690 | 1 | 0 | |a LEUKOCYTE ACTIVATION |
| 690 | 1 | 0 | |a PRIORITY JOURNAL |
| 690 | 1 | 0 | |a PROTEIN SYNTHESIS |
| 690 | 1 | 0 | |a CELLS, CULTURED |
| 690 | 1 | 0 | |a CORTICOTROPIN-RELEASING HORMONE |
| 690 | 1 | 0 | |a CYCLIC AMP |
| 690 | 1 | 0 | |a GENE EXPRESSION REGULATION |
| 690 | 1 | 0 | |a HUMAN |
| 690 | 1 | 0 | |a INTERLEUKIN-1 |
| 690 | 1 | 0 | |a LIPOPOLYSACCHARIDES |
| 690 | 1 | 0 | |a MONOCYTES |
| 690 | 1 | 0 | |a RNA, MESSENGER |
| 690 | 1 | 0 | |a SIALOGLYCOPROTEINS |
| 690 | 1 | 0 | |a SUPPORT, NON-U.S. GOV'T |
| 700 | 1 | |a Sauer, J. | |
| 700 | 1 | |a Castro, C.P. | |
| 700 | 1 | |a Finkielman, S. | |
| 700 | 1 | |a Stalla, G.K. | |
| 700 | 1 | |a Holsboer, F. | |
| 700 | 1 | |a Arzt, E. | |
| 773 | 0 | |d 1995 |g v. 136 |h pp. 5504-5510 |k n. 12 |p Endocrinology |x 00137227 |w (AR-BaUEN)CENRE-4573 |t Endocrinology | |
| 856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028847347&doi=10.1210%2fendo.136.12.7588301&partnerID=40&md5=fe62d97839d73f74e3a90cc265462184 |y Registro en Scopus |
| 856 | 4 | 0 | |u https://doi.org/10.1210/endo.136.12.7588301 |y DOI |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_00137227_v136_n12_p5504_Pereda |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00137227_v136_n12_p5504_Pereda |y Registro en la Biblioteca Digital |
| 961 | |a paper_00137227_v136_n12_p5504_Pereda |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/article |a info:ar-repo/semantics/artículo |b info:eu-repo/semantics/publishedVersion | ||
| 963 | |a VARI | ||
| 999 | |c 73470 | ||